Clinical trial
Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan.
NCT02272439 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan.
- Lead sponsor
- University of Saskatchewan
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- January 31, 2015
- Enrollment
- 118 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
male infertility, polycystic ovarian syndrome, unexplained infertility